Home›Companies›Biotech & Pharma›Reunion Neuroscience

Reunion Neuroscience, Inc.

Updated Oct 27, 2026·Latest SEC filing Sep 9, 2025·Suggest an edit

About Reunion Neuroscience

Reunion Neuroscience is a private company based in Morristown, New Jersey, incorporated in 2023 in Delaware. It has reported $119,850,000 raised in one offering on Form D since January 2024.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jan 12, 2024Jan 25, 2024amended Sep 9, 2025$119,850,000fully sold9$13.3MEquityRule 506(b)Form D/A ↗3 earlier filings

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Reunion Neuroscience's Form D filed Sep 9, 2025.

GM
Gregory Mayes
Executive officer and director
ME
AG
Ansbert Gadicke
Director
Also a director at NextPoint Therapeutics.
NS
EL
Ellen Lubman
Director
MP
Mark Pollack
Executive officer
NB
Nathan Bryson
Executive officer
MT
Mark Theeuwes
Executive officer
ES
Edward Smith
Chief Financial Officer

Sources

  1. SECReunion Neuroscience, Inc. Form D/A, filed May 5, 2025
  2. SECReunion Neuroscience, Inc. Form D/A, filed May 6, 2024
  3. SECReunion Neuroscience, Inc. Form D, filed Jan 25, 2024
  4. SECReunion Neuroscience, Inc. filing history